• Profile
Close

Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma

European Journal of Cancer Aug 23, 2018

Kozuma Y, et al. - Experts gauged the association between indoleamine 2,3-dioxygenase 1 (IDO1) expression in lung adenocarcinoma and clinicopathological features and patient prognosis, including the expression of programmed cell death-ligand 1 (PD-L1). An aggressive form of lung adenocarcinoma may be defined with IDO1 and PD-L1 co-expression. In lung adenocarcinoma cell lines, both proteins were upregulated by treatment with interferon-γ and transforming growth factor-β. In multivariate analysis, findings suggested a significant association of co-expression of IDO1 and PD-L1 with shorter disease-free survival and overall survival.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay